Navigation Links
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Date:4/28/2008

Food and Drug Administration (FDA) a supplemental regulatory

application for the additional use of the PROCLEIX ULTRIO assay to

screen donated blood for hepatitis B virus (HBV). The FDA approved the

assay to screen donated blood for HIV-1 and hepatitis C virus in late

2006. The Company is seeking approval to use the assay to screen for

HBV on both its semi-automated instrument platform and on the fully

automated, high-throughput TIGRIS system.

-- HPV Clinical Trial Begins. On March 31, Gen-Probe announced that the

Company had begun a pivotal U.S. clinical trial of its investigational

APTIMA assay to detect HPV, which causes cervical cancer. The

investigational APTIMA HPV assay is an amplified nucleic acid test that

is designed to detect 14 high-risk HPV types that are associated with

cervical cancer. More specifically, the assay is designed to detect two

messenger RNAs (mRNAs), E6 and E7, which are produced in higher amounts

when HPV infections progress toward cervical cancer. Gen-Probe expects

to enroll approximately 7,000 women in the study. Actual enrollment,

however, may vary based on the prevalence of cervical disease among

women in the trial. The trial enrollment and testing are expected to

take approximately two years.

-- Two PCA3 Studies Published. The leading peer-reviewed Journal of

Urology(R) published two important articles that the Company believes

illustrate the value of Gen-Probe's prostate cancer marker PCA3. In

the first article, "PCA3: A Molecular Urine Assay for Predicting

Prostate Biopsy Outcome" (Volume 179, Issue 4, Pages 1587-1592,

April 2008), researchers from the Urological Sciences Research

Foundation, The Johns Hopkins University, the University of Washington,

DiagnoCure and Gen-Probe conclude that PCA3 is
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
2. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
3. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
4. Carl Hull Named President and Chief Operating Officer of Gen-Probe
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Gen-Probe to Webcast Three Upcoming Presentations
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
9. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
10. CV Therapeutics Reports 2008 First Quarter Financial Results
11. Caliper Life Sciences Reports West Coast Consolidation of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, Inc. ... the treatment of chronic pain, announced the results of ... "This was a transformational year in Relmada,s history ... for our company," said Sergio Traversa , chief ... have executed on key financial, human resource and clinical ...
(Date:12/17/2014)... Based on the revenues gained from surgical imaging ... by four major players contributing to approximately 74% ... GE Healthcare (U.K.), Siemens AG (Germany), Philips (Netherlands), ... Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html , The leading ... its strong product portfolio, which includes its flagship ...
(Date:12/17/2014)... 2014 Achim Noack has been named ... Group. In this position, Noack will assist Jerry Stoller, ... develop marketing strategy and supervise global marketing management and ... has tremendous knowledge and experience in the crop protection ... experience and innovative thinking will be a great asset ...
(Date:12/17/2014)... 17, 2014 Once more, EMAAR ... larger packaged waste water treatment plant to phase one ... City (KAEC). Two years ago Bioshaft successfully supplied and ... serving two residential towers with an occupancy of 900 ... quarter million gallons per day and was signed on ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... Coinstar, Inc. (Nasdaq: CSTR ) today ... healthcare technology company that develops and deploys health ... product and the next-generation SoloHealth Station™.  Investment details ... leader in automated retail, Coinstar is continually looking ...
... ICAP Ocean Tomo will auction a ... March 31st at the ICAP Ocean Tomo Spring 2011 ... this patent portfolio provides improvements to existing nebulizer devices. ... technological advancements have triggered the use of nebulizers for ...
... Reportlinker.com announces that a new market research report ... Global Nanobiotechnology Industry http://www.reportlinker.com/p0181059/Global-Nanobiotechnology-Industry.html ... markets for Nanobiotechnology in US$ Million by the ... Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, ...
Cached Biology Technology:Coinstar to Invest in SoloHealth 2Coinstar to Invest in SoloHealth 3ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air 2ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air 3ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air 4Reportlinker Adds Global Nanobiotechnology Industry 2Reportlinker Adds Global Nanobiotechnology Industry 3Reportlinker Adds Global Nanobiotechnology Industry 4Reportlinker Adds Global Nanobiotechnology Industry 5Reportlinker Adds Global Nanobiotechnology Industry 6Reportlinker Adds Global Nanobiotechnology Industry 7Reportlinker Adds Global Nanobiotechnology Industry 8Reportlinker Adds Global Nanobiotechnology Industry 9Reportlinker Adds Global Nanobiotechnology Industry 10Reportlinker Adds Global Nanobiotechnology Industry 11Reportlinker Adds Global Nanobiotechnology Industry 12Reportlinker Adds Global Nanobiotechnology Industry 13Reportlinker Adds Global Nanobiotechnology Industry 14Reportlinker Adds Global Nanobiotechnology Industry 15Reportlinker Adds Global Nanobiotechnology Industry 16Reportlinker Adds Global Nanobiotechnology Industry 17
(Date:12/5/2014)... Utah , Dec. 4, 2014  Tute Genomics, ... raised $2.3 million in Series A1 funding led by ... investors also participated in the investment round. ... the healthcare community adopts next-generation sequencing and seeks new ... said Reid Robison , MD MBA, and CEO ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
(Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... many common laboratory techniques, such as DNA sequencing and ... of traditional university or industrial settings, giving rise to ... DIYbio.org and the Synthetic Biology Project at the ... a Biosafety Expert" service in order to ...
... amongst individual species within the animal kingdom evolved from ... serve as medical research models because humans and mice ... to morphological and behavioral complexity, a growing body of ... by a family of DNA-binding proteins called "transcription factors." ...
... changes since the early 1960s have fueled a sharp increase ... food consumed by the average person over the course of ... at McGill University. Between 1961 and 2007, rising meat ... the world,s per capita "phosphorus footprint," the researchers conclude in ...
Cached Biology News:Questions about biosafety? Ask a biosafety expert 2New key to organism complexity identified 2New key to organism complexity identified 3New key to organism complexity identified 4Dietary shifts driving up phosphorus use 2
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
... ZMD.473. Immunogen: Synthetic peptide derived ... mouse junctophilin-2. Specificity: Specific for ... (positive controls: mouse skeletal muscle homogenates ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: Store ...
Laminin gamma-2 (G-16)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Biology Products: